Randomized trial to assess bone mineral density (BMD) effects of zoledronic acid (ZA) in postmenopausal women (PmW) with breast cancer

被引:0
|
作者
Tevaarwerk, A.
Stewart, J. A.
Love, R.
Binkley, N. C.
Black, S.
Eickhoff, J.
Mulkerin, D. L.
机构
[1] Univ Wisconsin, Madison, WI USA
[2] Ohio State Univ, Columbus, OH 43210 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
19558
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Is BMD (Bone Mineral Density) a prognostic factor for luminal A breast cancer in postmenopausal women?
    Lee, Seungju
    Kim, Hyun Yul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
    Kang, Taewook
    Park, Si Young
    Lee, Soon Hyuck
    Park, Jong Hoon
    Suh, Seung Woo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (13)
  • [3] Study of bone mineral density (BMD) in postmenopausal women
    Dharmalingam, M
    Kumar, KMP
    Patil, J
    KarthikShankar, S
    BONE, 2003, 32 (05) : S178 - S178
  • [4] Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial.
    Brufsky, A
    Harker, WG
    Beck, JT
    Carroll, R
    Tan-Chiu, E
    Seidler, C
    Lacerna, L
    Thomas, E
    Perez, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 12S - 12S
  • [5] Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
    Reid, IR
    Brown, JP
    Burckhardt, P
    Horowitz, Z
    Richardson, P
    Trechsel, U
    Widmer, A
    Devogelaer, J
    Kaufman, J
    Jaeger, P
    Body, J
    Meunier, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09): : 653 - 661
  • [6] Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients
    Seung Ah Lee
    Seung Hyun Hwang
    Sung Gwe Ahn
    Hak Min Lee
    Joon Jeong
    Hy-De Lee
    Breast Cancer Research and Treatment, 2011, 130 : 863 - 870
  • [7] Effects of zoledronic acid on bone mineral density during aromatase inhibitor treatment of Korean postmenopausal breast cancer patients
    Lee, Seung Ah
    Hwang, Seung Hyun
    Ahn, Sung Gwe
    Lee, Hak Min
    Jeong, Joon
    Lee, Hy-De
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 863 - 870
  • [8] Randomized Trial of Adjuvant Zoledronic Acid in Postmenopausal Women With High-Risk Breast Cancer
    Leal, Ticiana
    Tevaarwerk, Amye
    Love, Richard
    Stewart, James
    Binkley, Neil
    Eickhoff, Jens
    Parrot, Benjamin
    Mulkerin, Daniel
    CLINICAL BREAST CANCER, 2010, 10 (06) : 471 - 476
  • [9] Bone mineral density in postmenopausal women with and without breast cancer
    Conde, Delio Marques
    Costa-Paiva, Lucia
    Martinez, Edson Zangiacomi
    Pinto-Neto, Aarao Mendes
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (06): : 673 - 678
  • [10] Bone mineral density and breast cancer risk in postmenopausal women
    Buist, DSM
    LaCroix, AZ
    Barlow, WE
    White, E
    Weiss, NS
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (04) : 417 - 422